ALKS 4230 (Nemvaleukin alfa)

Nemvaleukin alfa · Alkermes plc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALKS 4230 (Nemvaleukin alfa), covering 2024-10-16 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors [Phase 1, Phase 2]